GHK-Cu is one of the few peptides where the skincare world and the research peptide world landed on the same compound independently — and the science mostly holds up for both. It’s a naturally occurring tripeptide that binds to copper ions, found in human plasma, saliva, and urine. Levels decline with age, tracking closely with reduced tissue repair capacity, which is what drew researchers to it in the first place.

From what we’ve found, the evidence base here is stronger than most peptides in this space — particularly on the skin and wound healing side.

What the research supports

Research areaWhat studies look atEvidence
Collagen & skin remodelingCollagen and elastin production in dermal fibroblasts; wrinkle depth and skin firmness in human trials; head-to-head comparisons with vitamin C, retinoic acid, and Matrixyl 3000Human trials
Wound healingWound closure rates, angiogenesis, inflammatory markers (TNF-α), outcomes in diabetic and ischemic wound models; clinical data in surgical wounds and diabetic ulcersHuman + animal
Hair growthFollicle support via blood vessel formation; extension of anagen (growth) phase; inhibition of premature follicle shrinkage; dermal papilla cell activityPreliminary
Gene expressionModulation of genes related to collagen synthesis, antioxidant defense, inflammation, and DNA repair; broad genomic footprint across multiple tissue typesPreclinical

Collagen and wound healing data is the most consistent. Hair growth research is promising but variable. Gene expression findings are mechanistically interesting — clinical translation is still being worked out.

Collagen and skin remodeling is where the evidence is strongest. Multiple human trials found topical GHK-Cu meaningfully improved skin firmness, wrinkle depth, and collagen density. In head-to-head comparisons it outperformed both vitamin C and retinoic acid for collagen increases, and outperformed Matrixyl 3000 for wrinkle reduction. [VERIFY BEFORE PUBLISHING — confirm sourcing against PMC6073405]

Wound healing data is consistent across decades of animal research and extends into clinical work on diabetic ulcers and surgical wounds. Hair growth has plausible mechanisms but thinner data — results are more variable and less settled than the skin work. The gene expression findings are intriguing, but modulating genes and producing measurable research outcomes are two different things.

Research protocols

GHK-Cu is studied topically for skin and scalp applications, and as a subcutaneous injectable for systemic research. Common injectable frameworks use 1–2mg per injection, 3–5 days per week, over an 8–12 week cycle with an equal rest period.

Note: Injectable dosing is derived from published clinical practice patterns. No official clinical dosing guidelines exist. [VERIFY — cross-check against ManaWell 100mg vial specs before publishing]

How to reconstitute GHK-Cu

Add 2–3mL of bacteriostatic water to a 100mg vial. Inject the BAC water slowly down the inside wall of the vial — not directly onto the powder. Swirl gently until dissolved. Do not shake. The reconstituted solution will be clear with a faint blue tint from the copper. Discard if cloudy or if you see visible particles.

Storage

StateTemperatureDuration
Lyophilized (powder)−20°C (frozen)12+ months
Reconstituted2–8°C (fridge)2–4 weeks

Don’t refreeze once mixed. Allow frozen vials to reach room temperature before opening to prevent condensation getting into the vial.

GHK-Cu — 100mg

Available from ManaWell Research. US-based, third-party tested. Use code PROTOCOL10 for a PeptideRef discount.

Shop ManaWell →
All content on PeptideRef.co is for informational and research purposes only. Nothing on this site constitutes medical advice. All peptides referenced are intended for laboratory research use only and are not approved for human consumption. Always consult a qualified healthcare professional before making any health-related decisions. PeptideRef may earn affiliate commissions from qualifying purchases.